LONDON, Nov. 11, 2022 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce its participation in the following upcoming conferences in November. Jefferies London Healthcare Conference, November 15-17 George Tziras…


Previous articleatai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer
Next articlePT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home EEG Microdosing Study